Skip Navigation

Office of Research Development

Resources and Scientific Environment

Facilities & Resources


Research and Development Laboratories

Research buildings at MUSC include the Basic Sciences Building, a 7-story, 332,000 ft2 laboratory complex that houses MUSC’s basic science departments; Darby Children’s Research Institute, a 7-story, 122,000 ft2 building housing 14 multidisciplinary lab-based research programs, adjoining the Basic Science Building; the Thurmond Biomedical Research Building (STB), a 7-story, 180,000 ft2 building that contains the Gazes Cardiac Research Institute as well as MUSC and VA research labs and shared facilities; and Walton Research Building, an 8-story, 56,600 ft2 building housing research laboratories for Pathology, Otolaryngology-Head & Neck Surgery and Pharmaceutical Sciences. Two new research buildings opened in Fall 2011. Connected to the Basic Science Building via a pedestrian sky-bridge, the Drug Discovery and Bioengineering Buildings add 220,000 ft2 for translational research, research training and in vivo experimentation. Buildings that include significant research laboratory space as well as clinical facilities include the Institute of Psychiatry with 9 basic science laboratories for alcohol and substance abuse research and a behavioral animal model facility; the Storm Eye Institute with a 40,000 ft2 Vision Research Center; and the Hollings Cancer Center with a total of >200,000 ft2 including 98,000 ft2 dedicated to laboratory-based research. All laboratory investigators have well equipped modern laboratories with suitable space for students. Appropriate glassware and sterilization facilities are provided. All researchers at MUSC have access to shared equipment and standard resources such as ultra-low freezers, centrifuges, scintillation counters, and cold, warm, light-controlled and tissue culture rooms.

Darby Children's Research Institute

The Darby Children’s Research Institute (DCRI), the most comprehensive pediatric research facility in the Carolinas, provides 122,000 ft² of wet laboratory research space.  The Institute is home to research teams in eleven multidisciplinary programs that represent cardiobiology, Neurosciences, cancer biology, pharmacogenetics, addiction research, pulmonary biology, proteomics, vitamin D metabolism, osteoclast biology, autoimmune and rheumatic diseases, and renal biology.

Gazes Cardiac Research Institute

The Gazes Cardiac Research Institute (GCRI), one of the nation’s leading centers for heart failure research, is located in the Strom Thurmond Research Building.  This Building provides 113,416 ft² of research space and includes the Ralph H. Johnson Veterans Administration Medical Center.   The GCRI brings together a multidisciplinary group of investigators dedicated to understanding the biology of heart disease at the molecular level in order to promote the successful development of new therapies for heart disease.   The shared facility houses a range of talented physician scientists and translational investigators conducting a wide spectrum of research that includes cellular and molecular investigation, physiological studies in model systems, investigator-initiated clinical research, population studies and large corporate and NIH multicenter clinical trials.


MUSC Health

MUSC Health, the clinical enterprise of the Medical University of South Carolina (MUSC), is dedicated to the pursuit of changing what’s possible in health care. The innovations and leadership of this integrated health care system are evident, not only in the hospitals (University Hospital; Ashley River Tower, a cardiovascular, gastrointestinal, and cancer specialty hospital; the Institute of Psychiatry; the Storm Eye Institute; and Children’s Hospital) on the downtown Charleston campus, but shared through more than 100 outreach locations, clinical affiliations with numerous health care partners, and a robust telehealth network. MUSC Health serves more than one million patients annually, and its specialized care teams consistently rank among the best in the country.  MUSC Health delivers transformational care shaped by world-class clinicians, health scientists, and educators who provide leading-edge care, while developing the next generation of innovative health care leaders.

Medical Center data reported by John Cooper for the year ending June 30, 2018 include: 

Number of Licensed Beds plus 66 Neonatal Special Care713
Average Daily Census Rate686
Annual Admissions40,397
Number of Births2,693
Number of Outpatient Visits1,105,582
Number of Inpatient Surgical Procedures13,263
Number of Outpatient Surgical Procedures16,854

U.S. News & World Report  ranked MUSC Health the top hospital in South Carolina for 2017-2018 and among the best in the country when it comes to the treatment of ear, nose, and throat (ENT) disorders; gynecology; urology; and cancer. In addition to the national ranking for ENT, MUSC was categorized as a “high-performing” facility for the treatment of gastroenterology & GI surgery, geriatrics, nephrology, neurology & neurosurgery, orthopedics, pulmonology, and rheumatology.

MUSC achieved Magnet Recognition by the American Nurses Credentialing Center. Magnet Recognition, ultimate credential for high quality nursing, is a status held by only 7% of hospitals across the United States, and less than 1% of hospitals globally. The Magnet Recognition Program® recognizes healthcare organizations for quality patient care, nursing excellence and innovations in professional nursing practice.

MUSC Health Comprehensive Stroke and Cerebrovascular Center is the first stroke center in the state of South Carolina to achieve formal recognition as a Comprehensive Stroke Center by the Joint Commission. The certification recognizes those hospitals that have state-of-the-art infrastructure, staff and training to handle patients with the most complex forms of all strokes. It also recognizes the driving ambition of MUSC Health Stroke Program team leaders to relentlessly provide care that maximizes the chance for patients to make the best recovery possible. MUSC joins an elite group of about 100 hospitals nationwide.

Medical Center Research Mission. The Medical Center mission is to provide excellence in patient care, teaching, and research in an environment that is respectful of others, adaptive to change, and accountable for outcomes. The Medical Center advances biomedical knowledge by serving as a setting for clinical and translational research, providing resources to conduct research, and offering opportunities for patients to participate appropriately in research and treatment protocols.

Hospital Accreditation. The most recent Joint Commission on Accreditation of Healthcare Organizations (JCAHO) survey resulted in full re-accreditation. MUSC Medical Center is fully licensed by the South Carolina Department of Health and Environmental Control (SC DHEC).

Access to Patients. The MUSC Medical Center has managed care contracts with all major commercial payers in its area. The tri-county Charleston area is the state’s fastest growing region with a population of 665,000 in the primary area and another ~500,000 in the secondary market. A quarter of the state’s senior population lives in these catchment areas. As South Carolina's premier health care center, MUSC receives statewide and regional referrals through consortium hospitals, satellite clinics, and an extensive network of referring physicians. Data regarding inpatient and outpatient activity are provided above.

Clinical Trials.  The South Carolina Research Studies Directory,, enables South Carolinians to participate in research opportunities and novel treatment options available at MUSC as well as many of the other state’s hospitals. Participation in these treatment options (i.e., clinical trials) allows individuals to play an active role in their own health care and access new treatments before they become widely available. It also allows individuals to help others that may benefit in the future from their contribution to medical research.

MUSC Health Community Hospital
MUSC Health Community Hospital at Nexton will be a 311,221 ft2 facility with 128 beds, to provide a range of specialized inpatient and outpatient services. Estimated at a cost of $325 million, the project is expected to be operational in 2022. One of the area’s newest planned communities, Nexton is located in Summerville at the crossroads of I-26 and 17A in the path of metro Charleston’s vigorous growth.
“The Nexton hospital will be a much-needed addition to our health care system,” said MUSC President David J. Cole, M.D., FACS. “Our network of MUSC hospitals, clinics and other care facilities is positioned to provide patients with the right care, at the right time and in the right location. As the only publicly assisted, comprehensive, statewide academic medical center, MUSC has a mission and responsibility unlike any other health care facility in South Carolina. We are charged with discovering, developing, teaching and delivering the most advanced health care for every patient across the state.”
“We are committed to delivering top-quality care and increased access to every patient,” said Patrick J. Cawley, M.D., MHM, FACHE, MUSC Health CEO and vice president for Health Affairs, University. “To achieve this goal, we must position our health care network in synchronicity with the energetic growth of the greater Charleston community.”
MUSC Health Community Hospital at Nexton is designed to meet many of the increasing health care demands by bringing consistent, high quality and compassionate care to a convenient, neighborhood location.

Clinical Data Management System

MUSC has an integrated electronic health record (EHR) system that aligns patient access, patient management, revenue cycle, clinical systems and research. Our integrated EHR optimizes process efficiency and improves quality at each step of the continuum of care across the entire health-care system. In addition to in-house applications, there is now an active patient portal and a new portal for referring physicians. The system also provides additional levels of security and authentication for users and follows the Health Insurance Portability and Accountability Act for privacy and compliance.

Ashley River Tower

Ashley River Tower is a 641,000 ft2 facility that opened in 2008. The 156-bed hospital houses the inpatient units for Hollings Cancer Center, the Digestive Disease Center and the Heart and Vascular Center service lines. The facility includes three intensive care units; laboratories; interventional radiology and endoscopy suites; a specialized chest pain center; and nine operating rooms with integrated IT systems and specialized equipment for vascular surgery.

MUSC Children's Health

At MUSC Children’s Health we are imagining what’s possible for each and every child by providing the pediatric expertise your children deserves and needs. From promoting healthy lifestyles to offering life-saving treatments, we deliver comprehensive and compassionate care to children throughout South Carolina and beyond. Our integrated health care system consists of a 186-bed pediatric hospital providing the most advanced care possible in more than 26 specialty areas. We also provide the same depth and breadth of expertise in multiple neighborhood locations throughout the Lowcountry, offering primary, urgent and specialty care.  As a Level 1 Trauma center, our pediatric emergency department specializes in providing emergency care for any serious injury or illness your children may experience at home, at school or at play. Working collaboratively with pediatricians throughout the community, MUSC Children’s Health also provides after-hours care to children from birth to 17 years of age in three different locations on weeknights, weekends and holidays. In addition to the clinical care MUSC Children’s Health provides, we are a major pediatric clinical research center conducting significant and ongoing research efforts through the Charles P. Darby Research Institute. This involvement allows us to enhance our ability to provide the highest level of care to children by translating laboratory advances to bedside, developing new technologies and providing clinical trials. For more information visit
The MUSC Shawn Jenkins Children's Hospital and Pearl Tourville Women's Pavilion is scheduled to open in fall of 2019, this state-of-art hospital will cost $385 million, spanning 10-stories with 625,000 ft2. When the MUSC Shawn Jenkins Children’s Hospital opens, it will provide a critically important new space for women, mothers and newborn babies. The Pearl Tourville Women’s Pavilion, located on the fourth floor of the new hospital, will handle the toughest, most complex pregnancies and neonatal care. The pavilion will bring together a team of specialists and cutting-edge technology, while providing the necessary space to ensure that mothers and babies—and their families—can remain together throughout their hospital stays.

Hollings Cancer Center

The Hollings Cancer Center at the Medial University of South Carolina is the largest academic cancer center in South Carolina. It is the state's only National Cancer Institute (NCI) - designated cancer center and one of fewer than 70 in the U.S.  As the state’s foremost cancer treatment and research center, the Hollings Cancer Center unites more than 200 experts in treatment, research, education, prevention and control, and outreach to address South Carolina’s significant cancer problem. The Center’s resources extend throughout South Carolina via partnerships with other healthcare organizations, ensuring that all patients in the state have access to our innovative and compassionate care.  For the 27,000 South Carolinians who will be diagnosed with cancer this year, the Hollings Cancer Center is leading the way in changing what is possible in cancer care.

Ralph H. Johnson Veteran's Administration Medical Center

The Ralph H. Johnson VA Medical Center, opened in 1966, is a leading primary, secondary, and tertiary care facility located in Charleston, SC, serving over 70,000 Veterans along the coast of South Carolina and Georgia. The 149-bed hospital includes six community based outpatient clinics, a 20-bed nursing home, women's health, and the full range of inpatient and outpatient care, including medical and surgical intensive care. The VAMC provides more than 875,000 outpatient visits and approximately 4,400 in-patient stays annually. With more than 2,500 employees, Charleston VA has an annual budget of $458 million, research funding of more than $21 million, and more than 100 principle investigators participating in approximately 300 research studies.
The VA Research Program contributes significantly to the recruitment and retention of highly specialized clinical staff, many of whom are involved in research studies. Charleston VAMC’s Research and Development Service has a rich and sustained portfolio of innovative basic and clinical projects with an emphasis on translating research findings into cutting edge clinical practices for Veterans.  The Council on Accreditation of the Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC) commended the work of the Charleston VAMC for providing and maintaining an excellent program of laboratory animal care and use and renewed full accreditation.  This station has a VA non-profit research corporation, Charleston Research Institute, for accepting gifts, donations and grants to be used for VA research.
Significant areas of research include:

  • Basic Research in Cardiology, Endocrinology, Diabetes Mellitus, Hematology/Oncology, Regeneration Medicine, Rheumatology, Nephrology and Alcohol-Related Disorders.
  • Clinical Research in Mental Health, tele-mental health, PTSD, Hypertension and Aging
  • Health Services Research in rural health and health disparities
  • Rehabilitation research in stroke injury and tele-rehabilitation

The research program has also obtained and maintained accreditation of their animal program through the Association for the Assessment and Accreditation of Laboratory Animal Care (AAALAC), with re-accreditation accomplished in 2014.  
For the past two years, the Ralph H. Johnson VA achieved an overall annual 5-Star rating according to VA's Strategic Analytics for Improvement and Learning Value (SAIL) model. The Charleston VA is also ranked in the top 10th percentile according to the Healthcare Effectiveness Data and Information Set (HEDIS). HEDIS is an independent review that measures performance of 90 percent of America's health plans and facilities in both the public and private sector on dimensions of care and service.  Outpatient clinical/translational research activities are housed in a dedicated 2,800 square foot Clinical Research Unit (CRU) on the 2nd floor of the VAMC. The CRU has 10 examination rooms, a 4-station transfusion room, a 3-station physician workroom, a waiting room and a general laboratory with, centrifuge, several refrigerators, and a microscope. The CRU also includes a sterile specimen storage facility, staff offices, and break- and workrooms.  Construction for a new mental health research building broke ground in 2013 and was completed in the summer of 2015.  The final design reflects 14,929 of useable square footage of research space including: five wet labs, 27 exam rooms at 120 ft2 each, nine office at 120 ft2, record storage at 350 ft2 and miscellaneous other space.  The Mental Health Research building was designed to have four additional levels in the near future.  Numerous VA investigators have also received national awards for excellence such as the Wigger’s Award from the American Physiological Association, the Life time Achievement Award from the American Diabetes Association and most recently an award from the NIH.

Protection of Human Subjects

Participation of human subjects in research is under the jurisdiction of federal regulations (45 CFR 46 and 21 CFR 50 and 56). MUSC investigators are granted the privilege of working with human subjects under normal assurance to the government that such research complies with regulations protecting human subjects. The university has a federal-wide assurance for research with human subjects (FWA 00001888, expires 07/21/2019), and is in compliance with federal policy governing use of human subjects. Individuals involved in human subject research at MUSC are required to complete the Collaborative IRB Training Initiative (CITI) offered on-line by the University of Miami. All human subject protocols are reviewed through an academic Institutional Review Board (IRB) process that has been accredited by the Association for Accreditation of Human Research Protection Programs (AAHRPP).  The MUSC Office of Research Integrity (ORI) coordinates the activities of three IRB committees, involving faculty members as well as representatives of the business, legal, ethical, religious, and civic communities. These committees are registered at: The MUSC IRB serves as the university affiliate for the Ralph H. Johnson VA Medical Center, which is accredited by the National Committee for Quality Assurance.


The MUSC University Compliance Program is a proactive program designed to promote full compliance with all applicable policies, procedures, laws and regulations. This involves a confidential Compliance Helpline to encourage all members of the MUSC community to ask questions or voice concerns about laws and regulations on such topics as coding and billing, research integrity, professional ethics, human subject/animal research, biological safety, conflict of interests, and patient/subject confidentiality. The Compliance Office proactively trains employees, monitors high-risk activities, and facilitates discovery of concerns, followed by appropriate investigation and corrective action where appropriate. This program directly assists MUSC’s management at all levels in maintaining and enhancing an environment where ethics are paramount considerations in strategic and operational decisions throughout the organization.


Care and Use of Vertebrate Animals in Research

The Division of Laboratory Animal Resources (DLAR) centrally manages the University’s animal care program. The Institutional Animal Care and Use Committee (IACUC) is independently chartered and appointed by the President and is fully independent of DLAR. The IACUC reports to the Vice President for Academic Affairs & Provost. Committee functions are staffed by the Office of Research Integrity under the direction of the Associate Provost for Research. The IACUC is responsible for review of all proposals using lab animals at the university as well as oversight of the programs and policies associated with animal use. The committee meets monthly to review and approve animal protocols and address other issues. It performs semiannual inspections and review of the DLAR programs and facilities for compliance with PHS, USDA and AAALAC regulations. To help the IACUC in monitoring the conduct of animal-based research and proactively assist investigators in establishing and maintaining good practices, MUSC also has a program for Post-Approval Monitoring of Animal Use (PAMA). A designated Animal Research Compliance Liaison works with the MUSC investigators and the individuals who handle animals in their laboratories to ensure that the highest level of animal care is maintained and that all research involving animals is conducted with appropriate IACUC review and approval.

MUSC has been fully accredited by the Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC International) since 1987, with an unbroken record of compliance with regulatory inspections by the U.S. Department of Agriculture (USDA). MUSC’s Animal Welfare Assurance number is A3428-01 (expires 04/30/20).


Each laboratory has several networked PC and Apple computers and laser printers. The MUSC campus offers network access to computerized clinical data management systems, outpatient electronic medical records, Lanvision, Access Anywhere, IDX registration system, and the integrated laboratory system. Standard statistical software includes Epistat, SAS, SPSS, S-Plus, and M-Plus. DXCG and ACG software are available for patient case mix analysis. Microsoft Office (Word, Excel, Powerpoint) is the standard suite of office tools. All data are locally backed up through password-protected Apple TimeMachine hard drives and/or a Novell server while institutional protocols ensure long-term data security and protection.

MUSC Information Solutions provides information technology, informatics and analytics services for the academic health center.  It manages the campus-wide data and voice communication network as well as other core infrastructure systems and applications, with high-speed Ethernet network and Internet support with wireless access throughout the campus. Main infrastructure systems include Microsoft Exchange email, file storage, web servers, calendars, network identification and account maintenance, network time protocol, domain name system, and directory services. Core academic applications include the MUSC Library System, OVID, WebCT, SYBYL (molecular modeling), and GCG (gene sequence research). Core financial and administrative applications include GL, AP, financial reporting, purchasing, payroll, and human resources.

Access outside the MUSC firewall requires a VPN with two-factor verification. Free encryption service is provided for all laptops. Other data security elements include enterprise Public Key Infrastructure (PKI) service, advanced intrusion detection systems (IDS), Security Information and Event Management system (SIEM), and virtual machines (VMs) for research data management and analysis. Enterprise-wide process improvements include network access control, technical vulnerability management program and Data Center physical security. The MUSC Data Center is manned 24-hrs/day x 7 days a week by operations staff who monitor all servers, environmental conditions, and notify appropriate personnel as needed. The entire Data Center is protected by a card access system and 24-hr security cameras at each door entering and within the center. Weekly full-verified backup, daily differential verified backup and every-6-hr transaction log backup are captured by IBM® TSM system, Microsoft® Volume Shadow Copy service and Microsoft® SQL server, so that a new system can be restored using the backup tapes/files with minimal data loss in case of a catastrophic failure to a web or database server.  The university system is backed up on a nightly basis, data files are written initially to disk and staged to tape. Copies of the tapes are rotated offsite to vital records (3 months of taped backups are available at any given time). In the event of hurricanes or other natural disasters, two forms of backups will be performed to ensure that data are not lost: 1) the information system will keep timely backups available at the remote site, and 2) project personnel will be instructed to bring updated copies of their data on external hard-drives if evacuated.




Office areas at MUSC are well lighted ventilated and appointed for scholarly activities, paperwork, and modes of communication (voice, data, analog, digital, etc.) that are common and appropriate at a contemporary health professional university and academic medical center. Competent support staff and all standard office services and software are readily available to facilitate the academic and scientific activities of faculty, trainees, and technical staff.

Other Resources

The Medical University of South Carolina has more than 35 state-of-the-art shared research facilities physically housed in and administered by its departments, centers, and institutes.  Clinical research faculty basic scientists, and students all benefit from the shared access to and cost of these research laboratories. Through these diverse resources, MUSC provides access to equipment and instrumentation, technical expertise and training and education all designed to support innovative, cutting edge research.

Cores & Facilities

Antibody Facility
This facility has ended.

Bioinformatics Shared Resource
The MUSC Bioinformatics Shared Resource (BSR) provides state of the art bioinformatics analysis for genomic and epigenomic assays and supports the research goals of MUSC investigators. A range of bioinformatics services that have proven to be transformative in enabling investigators to advance disease-related research goals are offered. An emphasis will be placed on strengthening local bioinformatics resources, leveraging state resources (including the high-performance Palmetto computing (HPC) resource at Clemson University), and reducing barriers to utilization of bioinformatics tools by the MUSC community.

Biorepository & Tissue Analysis Shared Resource
The Biorepository & Tissue Analysis Shared Resource at MUSC and the Hollings Cancer Center provides investigators with access to meticulously collected and annotated human specimens as well as advanced human and animal tissue analyses that require state-of-the-art instrumentation and expertise. The shared resource is comprised of several integrated components: biospecimen and data repository, customized and readily available tissue microarrays, laser capture microdissection, matrix-assisted laser desorption/ionization tissue imaging, and research pathology services such as histologic analysis of fixed, frozen, and stained tissues and analysis of experimental results.

Biostatistics & Epidemiology Collaborative Unit
The Collaborative Unit, housed within the Department of Public Health Sciences, is a university-wide resource facility providing expert consultation in biostatistics, bioinformatics, and epidemiology. Services include assistance in design of observational studies and experiments; selection of data collection instruments and data management systems; selection, application, interpretation, and reporting of epidemiological, bio-mathematical, environmental risk assessment, and statistical methods; graphical analysis of data; sample size estimation; and selection of statistical, graphical and database software packages. The unit assists in preparing the biostatistical and epidemiological narratives associated with grant proposals, and with presentations and publications following the research. The unit supports faculty across campus to develop competitive grant applications, and it also provides a training experience for DPHS trainees interested in developing skills in applying quantitative tools.

Biostatistics Shared Resource
The Biostatistics Shared Resource at the Hollings Cancer Center provides biostatistical support to cancer center investigators. The primary mission includes study design and statistical analysis. Biostatistical support is essential for cancer researchers to develop rigorous study designs to efficiently manage data, and to make maximum use of data collected for informed conclusion. Early statistical input into the design of experiments increases the efficiency of investigations and improves the quality of research. The resource provides services that span all types of cancer research including cancer clinical trials, cancer prevention studies, epidemiologic studies, animal studies, and other laboratory studies. Hollings Cancer Center members are encouraged to utilize Biostatistics Core resources for development of cancer related grants and protocols (to be submitted to federal as well as private agencies), and help in answering the biostatistical related questions and suggestions of the external reviewers.

Brain Stimulation Core
Brain Stimulation Core (BSTIM) provides direct support to the investigators of the South Carolina Research Center for Recovery from Stroke COBRE.  The Core supports a unique activity for SCRCRS, building on strengths at MUSC. BSTIM methods are used to measure brain function, excitability and plasticity as well as to induce brain changes to potentially treat damage caused by stroke. Thus, BSTIM tools may be used for quantitative measurement or as plasticity modifying agents, or both. The overall goal is to establish BSTIM as a signature resource to provide essential expertise for SCRCRS investigators and develop unique tools, methods and potential treatments to enhance their research.

Cell Evaluation & Therapy Shared Resource
The Cell Evaluation & Therapy Shared Resource offers the Hollings Cancer Center (HCC) investigators comprehensive analytic flow cytometry and high-speed cell sorting services and the capacity to generate human cellular and tissue-based products for use in translational research. The mission of the Shared Resource is to provide an integrated platform where HCC users can evaluate pre-clinical or clinical experimental data in a cell-specific manner and then convert this knowledge using the cell-manufacturing facility to take a cellular product into patients.  Immune monitoring services are embedded in this resource and make use of flow cytometry and other technologies that can be used to evaluate the immune response in patients and provide valuable data needed for more basic laboratory investigations in animals or tissue culture. The Shared Resource consists of two synergistic and coordinated units – the Flow Cytometry and Cell Sorting Unit and the Cell Growth & Therapy Unit.

Cell and Molecular Imaging Shared Resource
The Cell and Molecular Imaging Shared Resource provides members of the Hollings Cancer Center (HCC) with a fully supported suite of state-of-the-art imaging capabilities. These capabilities include imaging at the cellular, tissue, intravital, and in vivo whole animal levels.  The CMI Shared Resource consists of two synergistic and coordinated units – the Confocal & Multiphoton Microscopy Unit and the Small Animal Imaging Unit.

In addition to providing state-of-the-art imaging, the shared resources provides consultation and assistance concerning experimental design, sample preparation, probe selection, data analysis for imaging applications, and transitioning microscopic evaluations to whole animal imaging.  Investigators receive in depth training in multiple imaging modalities and education in the fundamentals of imaging technology and its application.  The Cell and Molecular Imaging Shared Resource is also a part of the Center for Cell Death, Injury and Regeneration.

Cell Growth & Therapy Unit
The Cell Growth & Therapy Unit staff has extensive experience in all aspects of cellular therapy and Good Manufacturing Practice, cGMP, Phase I/II manufacturing of autologous cellular products. These include cGMP handling of blood components; dendritic cells, mesenchymal stem cells, T-cell & immunotherapy expertise; and clinical experience in transplantation and cellular therapies.  In addition to technical expertise, extensive QA/QC and regulatory experience are available to ensure FDA compliance during the development of each specific cellular product. The Unit is dedicated to scaling up translational studies within the HCC and supporting investigator-initiated clinical trials involving cellular therapy. Support includes technology transfer from the research laboratory to the clinical setting as well as scale-up and validation studies.  Additional services are available for Immune Monitoring.

The unit consists of three components:  a 200 ft2 Process Optimization Lab, a 200 ft2 materials Management/QC Laboratory, and a 1000 ft2 clean room suite comprised of manufacturing rooms, general processing area, storage, gowning and de-gowning areas. The cGMP clean room suite contains three annually certified ISO 14644-1 compliant Class 6 manufacturing rooms. Each of these is a fully functional processing laboratory. In addition, each room contains at least one Class 5 Biological Safety Cabinet (BSC) for performing open system sterile processing. The largest of these rooms contains two BSCs.  Additional processing equipment includes two COBE 2991 automatic cell processors, a CliniMacs for subset isolation, and centrifuges enabling cell separation. Multiple CO2 incubators and inverted phase microscopes allow all phases of cellular isolation, culture, differentiation, and packaging of final product to be performed inside the clean room environment. An in-lab Accuri C6 flow cytometer is available for cell subset identification and analysis. Sterility testing, including mycoplasma and endotoxin, is performed as required per FDA guidelines. In addition, this laboratory has dedicated refrigerated centrifuges, incubators, microscopes, a Cole Parmer sterile tube welder/sealer, a tabletop autoclave, and controlled rate and cryogenic storage freezers.

Clinical Trials Office
The Hollings Cancer Center (HCC) Clinical Trials Office (CTO) provides a centralized office for the conduct of cancer clinical trials at the Medical University of South Carolina (MUSC). The purpose of the CTO is to provide an effective and efficient clinical research infrastructure to support investigators and clinicians in developing and implementing clinical research studies.  This shared resources provides training and education relevant to all aspects of study management to clinical staff and new investigators. Other services include:

  • Assistance for HCC Principal Investigators in the activation and administration of studies
  • Centralized support for scientific, ethical, financial and operational reviews and ongoing management
  • Communication of the availability of clinical studies to HCC physicians, referring physicians and the public
  • Preparation of records for internal and external quality and compliance audits
  • Assistance for clinicians in screening and enrolling patients for clinical research studies
  • Coordination of the completion of patient-specific study requirements
  • Data management support for clinical research studies
  • Multi-center management support services for investigator-initiated trials

For a full listing of current clinical trials, please search our Clinical Trials Database.

Comparative Effectiveness and Data Analytics Research Resource
CEDAR maintains a registry of resource rich data sets from national, statewide and regional sources, such as: Medicare 5% sample, MarketScan® billing data, HCUP Nationwide Sample and HCUP SID data from 17 states, NHANES and BRFS data, and SC Social Determinants of Health. The center also partners with other data suppliers to enhance access to critical repositories, and has expert faculty well-versed in maximizing the research potential of these resources. CEDAR provides controlled use of these data for research purposes and ensures compliance with data use and licensing agreements. The objectives of CEDAR are to:

•    Curate information about the types of archival data resources available on campus
•    Disseminate information on the available data to faculty and students
•    Train faculty and fellows in archival data study design and analysis methods
•    Provide governance for access to existing data sets on campus
•    Support investigators in developing new studies using archival data

Computational Biology Resource Center
The Computational Biology Resource Center (CBRC) is a state-of-the-art computational infrastructure for scientists to apply advanced computer algorithms to biological problems. Toward reaching this goal, the CBRC has purchased and maintains a 16 node 132 CPU computing cluster combined with multi terabit storage capacity. The cluster is a LINUX-based system aimed at supporting a host of bio-databases as well as applications in drug discovery, NMR, x-ray crystallography, DNA microarray analysis, bioinformatics, image analysis and molecular modeling.

Confocal & Multiphoton Microscopy Unit
The Confocal & Multiphoton Microscopy Unit of the Cell & Molecular Imaging Shared Resource provides live cell imaging of parameter-sensitive fluorophores, high resolution imaging of tissue sections for immunocytochemistry and fluorescent protein distribution, fluorescence resonance energy transfer (FRET) and fluorescence recovery after photobleaching (FRAP) to characterize and quantify interactions between specific molecules and their mobility, and intravital microscopy to monitor microcirculation.  

This resource is equipped with the following instruments:

  • Zeiss LSM 510 NLO META multi-photon laser scanning confocal/multiphoton microscope
  • Zeiss LSM 510 META: Similar to the above microscope with the exception of the multiphoton capability
  • Olympus FluoView FV10i LIV
  • Olympus FV1200 MPE
  • Leica TCS SP2 AOBS
  • Fluorescence Plate Reader

Data Coordination Unit
The Data Coordination Unit (DCU), housed within the Department of Public Health Sciences provides assistance with the design of clinical trials and analysis of their data and in establishing, implementing and maintaining data and project management systems for multicenter clinical trials. The DCU has expertise in the design and conduct of Phase I through III trials in a variety of therapeutic areas including neurology, digestive diseases, psychiatry, and diabetes, as well as trials conducted under FDA Investigational New Drug/New Device applications. All trial management activities are conducted using the DCU’s internally developed Clinical Trials Management System (CTMS) referred to as the WebDCU™ system. The WebDCU™ offers a full collection of web-enabled modules for central randomization, protocol and site management (e.g., drug accounting and shipping, automated SAE reporting, regulatory document tracking), study monitoring, safety reporting, data entry and validation, and report generation. The system provides a web-based collaborative environment for study team members across all participating clinical sites and provides all the required tools for site coordination and data management in one efficient and easy to use system. 

Flow Cytometry Facility
Flow Cytometry Facility serves to provide information and encourage individual researchers to bring their expertise in cell proliferation, extracellular signaling, intracellular signaling, cell adhesion, cell migration, or gene regulation to bear on studying the biological properties of stem cells. This facility offers technical information and training to guide investigators in using stem cells to enhance their individual research interests or scientific expertise. Through this facility, investigators can arrange training and tutorials in procedures to isolate, clone, store, and culture stem cells from adult bone marrow, cord blood, or established cell lines.

Equipment available to the facility includes: Becton Dickinson FACSVantage flow cytometers with five fluorescent detectors for use in complex cell sorting; tissue culture hoods and incubators; a Cryomed Programmatic Cell Freezing system with an MVE Cryogenic Liquid Nitrogen Freezer for keeping cells long-term; and computer workstations for visiting faculty and students.

Flow Cytometry & Cell Sorting Unit
The Flow Cytometry & Cell Sorting Unit of the Cell Evaluation and Therapy Shared provides comprehensive analytic flow cytometry and high-speed cell sorting services to Hollings Cancer Center (HCC) investigators. The facility staff members have considerable expertise in high-speed sorting of rare populations of cells including stem/progenitor cells and epitope-specific T cells and are continually expanding the repertoire of available techniques to meet the needs of the innovative research within the HCC.

This resource offers a wide range of services from access to routine flow cytometric analysis to expertise in high-speed cell sorting to the development of novel assays. Examples of assays available include, but are not limited to: immunophenotyping, cell cycle analysis, DNA ploidy analysis, apoptosis, cell proliferation (BrdU incorporation), intracellular antigen/protein and membrane potential measurement, as well as cytokine detection (bead assay). High-speed cell sorting based on cell surface marker immunostaining and/or side-population staining is also available.

Facility supports the following equipment:

  • Becton Dickinson FACSVerse
  • Becton Dickinson FACSCalibur Analytical Flow Cytometer
  • Becton Dickinson LSRFortessa Analytical Flow Cytometer
  • Becton Dickinson FACSAria IIU Cell Sorter
  • Beckman Coulter MoFlo XDP High-Speed Cell Sorter

Fluorescence Imaging Plate Reader Facility - (FLIPRTETRA®, Molecular Devices)
The FLIPRTETRA® purchased through a shared instrumentation award obtained from NIH under the American recovery and Reinvestment Act of 2009 (NCRR 1S10RR027777-01) is an industry-renowned instrument for monitoring GPCRs and ion channels. The system provides a reliable and flexible high throughput screening solution for identifying early leads in the drug discovery process. FLIPRTETRA®, features 96, 384 and optional 1536 well configurations, multi-wavelength kinetic readings, LED modules and user configurable excitation and emission filters, and enhanced luminescence sensitivity with the aequorin luminescence camera. With the user configurable LED excitation modules, the FLIPRTETRA® has been used for the following assays: membrane potential, intracellular pH, sodium and calcium, reactive oxygen species, nitric oxide, c-AMP (utilizing GLO-sensor cells; Promega, Inc) and others. The FLIPRTETRA® is optimized for use with both fluorescent and luminescent assays, including aequorin and Molecular Devices' no- wash FLIPR® calcium and ion channel assays.

Experiments must be pre-consulted with Dr. Mi-Hye Lee, facility manager, to assure that they are feasible and that the properdyes are available. All disposables are provided by user (plates, dyes, buffers). Subsequent to initial training session, reservations can be made utilizing the on-line calendar.  The FLIPRTETRA® facility is located in room 519 Strom Thurmond Biomedical Research Center.

Gene Function Core
The Gene Function Core (GFC)  mission is to support investigators in the application of genetically modified mice or rats by providing the following services: (1) Expertise and technology required to generate DNA constructs for the production of genetically modified mice or rats; (2) Generation of genetically modified mice/rats by both “typical” transgenic and ES approaches, or CRISPR/Cas; (3) Sperm cryopreservation and strain rescue; and (4) Xenograft experiments for cancer researchers. This Core integrates two existing state-of-the-art intramural core facilities, the Transgenic Facility and the Gene Targeting Facility, with mentoring and training to facilitate the application of mouse models. The Gene Function Core generates genetically modified mice by pronuclear injection of the fertilized zygotes and offers gene “knockout”, Cre-conditional knockout mice, and production of genetically mutant mice containing site-specific mutations (ranging in size from 1bp to over 100 Kbp). The Core now offers the possibility of making genetically modified mice in the C57BL/6 strain to eliminate the time-consuming process of genetic backcrosses and to facilitate assessment of genetic modifier effects.

Genomics Shared Resource
The Hollings Cancer Center Genomics Shared Resource at MUSC offers state of the art next generation sequencing (NGS) including DNA-Seq, RNA-Seq, ChIP-Seq, Methyl-Seq, Targeted sequencing utilizing Illumina HiScanSQ and Ion Torrent instrumentation.  In addition to NGS, Bead-Array analyses for GWAS, RNA expression and other analyses are available.
This Shared Resource supports the following equipment:
  • Illumina HiScanSQ micro-array scanner and HiSeq sequencerIllumina cBot Cluster Generation System
  • Ion Torrent PGM sequencer
  • Ion One Touch System
  • Agilent ® 2200 TapeStation
  • Sage Science Pippin Prep
  • Diagenode Bioruptor UCD-600 TS 
  • QuBit Fluorometer
  • IBM compute analysis, storage cluster

Gnotobiotic Animal Research Facility
The Gnotobiotic Animal Research Facility provides MUSC investigators and others a unique opportunity to conduct research with germfree or “gnotobiotic” animal models, in addition to more widely available specific-pathogen-free animal models. Located in the Darby Children's Research Institute, the facility is a joint initiative of the College of Dental Medicine, Center for Oral Health Research (COHR), University Research Resource Facilities program, and the Division of Laboratory Animal Resources (DLAR). A range of services are provided including: 1) derivation of new strains of mice into the germfree state; 2) germfree colony maintenance and management; and 3) production of germfree and defined flora mice (i.e. mice free of microbes or selectively colonized with one or more microbial species).

Irradiator Facility
The Irradiator Facility serves as a shared resource for the MUSC and under the direction of the Radiation Safety Office. The facility contains a JL Shepherd Model 143 137 Cesium irradiator. This equipment is designed to irradiate biological samples at variable doses. Adapters allow exposure for both tissue culture samples and small rodents.

Laser Capture Microdissection Facility
The state-of-the-art technology of Laser Capture Microdissection (LCM) Facility provides researchers with the ability to accurately analyze DNA, RNA and protein from pure populations of cells, such as tumor cells that are captured from complex heterogeneous tissue samples. Protocols have been developed and optimized for acquisition of high-quality RNA and DNA from both frozen and formalin-fixed, paraffin-embedded tissue. Care is taken to preserve the integrity of the samples at all times, ensuring high quality retrieval of molecular targets. Services provided in the LCM facility include:

  • Laser Capture Microdissection of pure populations of cells
  • DNA/RNA/protein extraction and QA/QC from microdissected samples
  • RNA/cDNA Amplification from microdissected, frozen, and FFPE tissues
  • Support for grant applications by providing LCM budgets and support letters

The establishment of the LCM shared resource is a combined effort of the College of Dental Medicine Center for Oral Health Research and the Hollings Cancer Center Tissue Biorepository. The Center for Oral Health Research provided significant support such as LCM equipment and partial salary support for LCM personnel. The LCM shared resource is housed in the Tissue Biorepository at Hollings Cancer Center, and is equipped with an ArcturusXT LCM system, Agilent Bioanalyzer, Leica CM 1850 Cryostat, and a Microm HM340E Microtome, which are available for a wide range of applications. Viability of the IR laser-enabled LCM technique has been shown for a variety of different cell types.

The LCM procedure is remarkably simple and robust. The method is extraordinarily gentle and ideal for microdissection of single cells or small numbers of cells. The LCM system utilizes a laser microbeam that melts a thermoplastic membrane that sticks to the selected cells, which can then be lifted and secured in a microfuge tube containing the appropriate extraction solutions. The transferred tissue on the film retains its original morphology, thereby allowing microscopic verification of the specificity of the captured material. Using this strategy, a single small cluster up to thousands of cells can be procured safely and without contamination. The Agilent 2100 Bioanalyzer and Nanodrop ND1000 monitor the quality and quantity of extracted RNA, DNA, as well as proteins from the LCM sample.

Lipidomics Shared Resource
The Lipidomics Shared Resource represents a novel scientific service that is unique to the Medical University of South Carolina and the Hollings Cancer Center. The Lipidomics Shared Resource builds on unique expertise at MUSC in sphingolipid biology, chemistry and analysis and their role in signal transduction and cell regulation. Sphingolipid metabolism assumes a key role in the complex mechanisms regulating cellular stress responses to environmental changes. Several sphingolipid metabolites act as bioactive molecules, and their individual contribution to the regulatory pathways that govern cell growth are being established. This offers promises for new molecular insights into tumor growth and metastasis and emphasizes the needs to analyze sphingolipid components, examine sphingolipid chemistry and regulation of sphingolipid metabolic pathways. Monitoring changes in sphingolipid composition in normal and cancer environments will provide one of the missing links in the search for a novel and effective therapy.

The Lipidomics Shared Resource includes analysis and synthesis units. Resource personnel provide conceptual and practical training in various aspects of lipidology, qualitative and quantitative analysis of lipid components from different biological materials (cells, tissue, biological fluids), synthetic molecular tools to study lipid metabolism (functionalized and fluorescent ceramides, site-specific radioactive sphingolipids), diversified synthetic lipids and analogs for cellular, in vitro, and in vivo studies (organelle-targeting sphingolipids and organelle-targeting inhibitors of sphingolipid metabolizing enzymes). Resource personnel also assist investigators in experimental design, selection of lipid of interest and interpretation of the analytical results. Analytical approaches are based on High Performance Liquid Chromatography-Tandem Mass Spectrometry (LC/MS) technology. This sensitive and specific analytical methodology can be applicable to a broad spectrum of diversified chemical compositions of sphingolipids and glycerolipids.

The Lipidomics Shared Resource has five functional chromatography/MS units that all use dual ionization modes: electrospray ionization (ESI) and atmospheric pressure chemical ionization (APCI).
  •  Four ThermoFisher TSQ Quantum triple-stage quadrupole mass spectrometers with super high pressure HPLC systems.
  •  A SCIEX 2000 Q-Trap triple quadrupole/ion trap combination instrument with outstanding sensitivity for improved detection limit and mass resolution connected to supercritical fluid chromatograph that allows separation and analysis of molecular species of GluCer and GalCer.
  • Instrumentation for lipid sample preparation and MS analysis: Atlas nitrogen generator for providing a steady supply of high purity nitrogen for optimal performance for both MS instruments, Savant speed-vacuum evaporator, two nitrogen evaporators, Beckman centrifuge, and Shimadzu UV-1601 spectrophotometer.

Mass Spectrometry Facility
The Mass Spectrometry Facility, housed within the Department of Pharmacology, provides expertise, services, education, and training to enhance biomedical research endeavors through mass spectrometry-based proteomics. Protein analysis includes in-gel or in-solution protease digestion, chromatographic separation and tandem mass spectrometric analysis of the resulting peptides, and interpretation of MS/MS data using Sequest, Mascot, Protein Pilot, MaxQuant, and other search algorithms. The facility also assists in the development of customized applications for the isolation, detection and characterization of posttranslationally modified peptides.  The COBRE in Oxidants, Redox Balance, and Stress Signaling, Mass Spectrometry Core is housed with the Mass Spectrometry Facility.

The Orbitrap Elite Mass Spectrometer provides services to couple quantitative approaches to modification-specific experiments. Investigators are developing methodology to analyze alterations in posttranslational regulation that impact signal transduction, epigenetic modulation, and the response to therapeutics with the goal of enabling investigators to discover molecular mechanisms underlying disease progression and therapeutic responses that may not be revealed through genomic studies.

The MALDI-TOF MS, LC-MS, and LC-MS/MS tandem mass spectrometry analyses are offered for protein analysis.  Protein identification services include in-gel or in-solution protease digestion, chromatographic separation and tandem mass spectrometric analysis of the resulting peptides, and interpretation of MS/MS data using Sequest® or Mascot® software. The facility will also assist in the development of customized applications for the isolation, detection and characterization of posttranslationally modified peptides.  Sites of modification are verified by manual inspection of the data.  Please consult facility staff for feasibility and pricing of quantitative proteomic experiments, the implementation of specialized approaches with quantitative proteomics, and MALDI-imaging mass spectrometry for tissue imaging experiments.

Mass spectrometers and associated proteomic applications available include:

  • Bruker Solarix 7T Dual Source MALDI/ESI FT-ICR MS (CID and ECD Fragmentation)
    MALDI Tissue Imaging, Top-Down Protein Characterization
  • Thermo Orbitrap Elite with VelosPro Ion Trap MS (CID, HCD, ETD Fragmentation)
    LC-MS/MS for identification, characterization of modifications, quantitation of differential protein expression or posttranslational modification using SILAC, iTRAQ®, TMT® , or label free approaches. Top-Down Protein Characterization.
  • Thermo LTQ XL Linear Ion Trap MS (CID, PQD, ETD fragmentation)
    LC-MS/MS for protein identification and characterization of fragile modifications.
  • Thermo LTQ Linear Ion Trap MS
    LC-MS/MS analysis for protein identification and characterization.
  • Applied Biosystems 4800 MALDI-TOF-TOF Proteomics Analyzer
    LC-MALDI-MS/MS for protein identification and quantitation of differentially expressed protein class="bodytext"using iTRAQ®, or TMT®  reagents.
  • Bruker Autoflex III MALDI-TOF-TOF MS
    MALDI Tissue Imaging
  • Bruker Autoflex III MALDI-TOF MS
    Molecular weight determination of intact proteins and peptides

Mineralized Tissue Facility
The Mineralized Tissue Facility (MTF) within the Center for Oral Health Research is dedicated to providing MUSC researchers with the equipment, techniques, and technical expertise necessary to study mineralized tissues.  MTF services are available to researchers investigating mineralized tissue biology and function at MUSC and other institutions. The facility is equipped with state of the art equipment and experienced staff to assist both new and experienced researchers:
  • The facility provides microCT scanning and analysis with a Scanco uCT40 ex vivo scanner with an analysis workstation and server. The scanner is capable of up to 6 um resolution scanning of samples up to 6 mm in diameter. 
  • Digital image acquisition and analysis services provided by an upright Olympus BX61 automated microscope equipped with a digital color camera and motorized stage, 1.25x-60x magnification, and brightfield and fluorescent illumination. 
  • Histological analysis of mineralized samples including the bones and dentition can present unique challenges.  The MTF offers several services to assist researchers in the generation and analysis of these samples. The facility operates specialized equipment, including a Microm HM360 motorized rotary microtome equipped with a tungsten carbide blade, Buehler diamond saw and grinder for generation of plastic and ground sections.

Molecular Modeling
A number of molecular modeling software packages are available to MUSC researchers via the Computational Biology Resource Center, which operates a 30 node 244 CPU Linux cluster. These include applications for homology modeling, ligand or protein-protein docking, molecular mechanics or dynamics simulations, electrostatics and in silico drug design.

Molecular Morphology and Imaging
The Molecular Morphology & Imaging core provides investigators with skilled personnel able to perform highly specialized techniques, such as echocardiography, in situ hybridization, and cell kinetics assays.  Services includes are: to assist the research projects perform state-of-the-art image and data analyses; to help design and perform in situ hybridization analyses; and to implement and maintain an online database of the data generated in this project.  MUSC investigators have access to core facilities to run their own experiments and are assisted by core staff concerning experimental design; data interpretation and technical information to best utilize facilities and instrumentation. The core falls into eight basic components: (1) basic microscopy (light, electron, and video); (2) confocal microscopy; (3) echocardiography; (4) histology (in situ hybridization, and immunohistology); (5) special techniques (laser capture; apoptosis and proliferation assays; optical mapping); (6) morphology, image analysis and statistics; (7) presentation graphics; and (8) data sharing technology.

Nephrology Proteomics Laboratory
The Nephrology Proteomics Laboratory is a state-of-the-art facility capable of separation and identification of proteins in tissue, cells and body fluids. The major interest of our laboratory is biomarker discovery and pathophysiology of renal diseases. To support this interest we perform liquid chromatography/mass spectrometry, 2D gel electrophoresis and other protein separation techniques. The facility is located in the Strom Thurmond Building at MUSC. The laboratory is a sample repository and analytical lab for the Southern Acute Kidney Injury Network (SAKInet) and the Southeastern Kidney Disease Consortium (SEKDC).
The MUSC nephrology proteomics lab has purchased a state-of-the-art mass spectrometer. The ABSciex 5600 Triple ToF mass spectrometer has brought exciting new capabilities to the lab for biomarker identification because of its extremely high mass accuracy and sensitivity. The instrument was purchased with a combination of funds from a VA grant and MUSC contributions. The mass spectrometer has been used to identify novel biomarkers that predict the development and progression of both diabetic nephropathy and acute kidney injury.

Neuroimaging Core
Neuroimaging Core (NI) provides direct support to the investigators of the South Carolina Research Center for Recovery from Stroke COBRE. The Core supports the quantitative measurement of plasticity and structural and functional connectivity; The Neuroimaging Core leverages resources within the Center for Biomedical Imaging (CBI), a designated University Center with the mission of advancing biomedical imaging at MUSC

Nuclear Magnetic Resonance Facility
The Nuclear Magnetic Resonance Facility (NMR magnet space total square footage 1,428 ft²) in the Drug Discovery building is designed to the strict stability criteria required for the very highest quality environment for NMR instruments.  NMR spectroscopy is a powerful technique that can provide detailed information on the three-dimensional structure of biological molecules in solution.


  • Bruker 400: A NanoBay Avance III 400, equipped with a 5 mm dual resonance, broadband inverse probe with an actively shielded single-axis gradient. A complementary Multinuclear Broadband Fluorine Observe (BBFO) probe exists for exotic X-nuclei observation. The current configuration allows operation in a two-channel setup.
  • Bruker 600: The Avance II 600 is currently equipped with a Quadruple Resonance (QCI)-Cryoprobe (H/C, N, P) purchased with support from NSF’s Major Research Instrumentation (MRI) Program (Award #1126230). Additional room temperature 5mm triple (H/C, N) and a quadruple (H,F/C,P) resonance inverse probe with actively shielded single- and triple-axis gradients exist as backups. The 600 spectrometer facilitates operations in a four-channel setup and is equipped with a CASE sample changer for automated analysis of up to 24 samples. 1H and 19F can be pulsed independently using two separate, high-band RF-channels.
  • Bruker 850: The high-field magnet 850 MHz is equipped with a TCI-cryoprobe triple resonance inverse probe. A room temperature Quadruple Resonance (QXI)-RT probe (H,F/C,N,) is available as a backup. The 850 spectrometer facilitates operations in a five-channel setup and is equipped with a CASE sample changer for automated analysis of up to 24 samples. 1H and 19F can be pulsed independently using two separate, high-band RF-channels.

The NMR facility serves as a research resounce and shared instrument facility for researchers at MUSC and in the region.  The facility offers access to state-of-the-art instrumentation and expert assistance in designing NMR experiments and applications.

In addition, researchers at MUSC have access to NMR instrumentation located at the Hollings Marine Laboratory (HML), a unique collaboration of governmental and academic agencies including NOAA, NIST, SC DNR, CofC and MUSC.  Access is based on the scientific merit of a project and relevance to the mission of the NMR facility as determined by the HML NMR council.  Potential users are welcome to discuss use of the 700 and 800 MHz spectrometers at HML with the MUSC NMR senior scientist.

Oral Preclinical Research Facility
The Oral Preclinical Research Facility provides services to investigators who studying oral related diseases. We offer several animal models, including a xenograft tumor model, 4NQO oral cancer model, periodontitis model, and oral mucositis model. Services include injection of tumor cells, 4NQO delivery, animal health monitoring, and imaging of tumor progression (in vivo), oral injections, animal irradiation, and animal dissection and tissue collection.

Protein Science Core
The Protein Science Core has closed.


ProteoGenomics Facility
The MUSC Proteogenomics Facility offers a range of RNA and DNA analysis services to the MUSC research community as well as to outside academic and corporate researchers. Primary services are profiling of RNA or DNA using microarray or next generation sequencing systems. Collectively, these systems can be used for high- or low-resolution expression profiling, expression panel screening, genotyping, metagenomics, etc. The facility will perform data analysis for these projects and/or will train investigators to perform their own analysis using proprietary and publicly available software. The facility also offers service and instrument access for qualification/quantification of RNA and DNA, including Bioanalyzer, real-time PCR and NanoDrop.

The facility provides free consultation to help investigators develop effective strategies and experimental designs, whether for funded or proposed projects. The facility is located in the Basic Science Building, room 633, within the Department of Regenerative Medicine and Cell Biology.

Instrumentation for service work:
  • Affymetrix Microarray System including GeneChip scanner, hybridization oven and two fluidics workstations.
  • Ion Torrent PGM System for next-generation sequencing
  • Agilent Bioanalyzer 2100
  • BluePippin for high resolution agarose gel fragment isolation
Instrumentation available for investigator use:
  • BioRad CFX 96 real-time PCR system and BioRad plate sealer
  • Monolight Luminometer for luciferase assays
  • Linux and PC workstations for data analysis
  • Software access: Ingenuity Pathway Analysis, dChip, MeV, plus
Data analysis support:
  • RNA expression analysis, including differential expression, process and pathway enrichment, clustering/heatmaps
  • Metagenomic analysis for the Ion 16S Metagenomics Kit workflow
  • Real-time PCR data analysis, training, reference genes and primer sequences

Quantitative Behavioral Assessment and Rehabilitation Core
Quantitative Behavioral Assessment and Rehabilitation Core (QBAR) provides direct support to the investigators of the South Carolina Research Center for Recovery from Stroke COBRE.   The Core supports a standardized experience and quantitative measurement of behavior and function; core services include motion capture and electromyography for precise measures of motion and muscle activity, energetics as measured by oxygen consumption, accelerometer-based devices for measuring activities such as walking and hemi paretic arm use, neuromuscular measures of strength and power of individual joints, clinical measures, and animal behavioral assay equipment. QBAR is located in the CHP research building.

Seahorse Metabolomics Facility
The Seahorse Meabolomics Facility is part of the Center for Cell Death, Injury & Regeneration and provides access to the XF Extracellular Flux Analyzer. This equipment is the industry standard for measuring cellular bioenergetics, simultaneously measuring the two major energy producing pathways of the cell – mitochondrial respiration and glycolysis - in a microplate, in real-time. This fast and sensitive measurement of cellular bioenergetics is label free, enabling time-resolved analysis and the reuse of the cells. XF assays provide increased throughput in a drug discovery format that is superior to its single parameter predecessors. This fast and sensitive measurement of cellular bioenergetics is label free, enabling time-resolved analysis and the reuse of the cells. XF assays provide increased throughput in a drug discovery format that is superior to its single parameter predecessors.

shRNA Shared Technology Resource
The shRNA Shared Technology Resource (short hairpin shRNA) will provide investigators at MUSC access to genome wide human and mouse libraries that together encode a total of almost 160,000 shRNA clones against over 41,000 genes. The resource utilizes The RNAi Consortium’s (TRC) genome-wide lentiviral mouse and human libraries and investigators will have the option of ordering shRNA’s targeting single or multiple genes, gene family sets as well as pathway specific pooled libraries. The library will allow access to multiple shRNAs for a single gene, which is important for validation against off target effects. This technology holds tremendous power, and is ready to help investigators at MUSC work toward breakthrough discoveries.

Small Animal Imaging Unit
The Small Animal Imaging Unit of the Cell & Molecular Imaging Shared Resource is a collaborative effort between the Center for Biomedical Imaging and the Hollings Cancer Center. The Small Animal Imaging Unit provides state-of-the-art instrumentation enabling noninvasive anatomical, metabolic, and functional imaging. By leveraging HCC cancer research experience with the facility’s extensive expertise in imaging, this unit is able to monitor cellular events such as tumor progression and metastasis in living animals. In vivo fluorescence and bioluminescence imaging is also used to evaluate tumor metabolism and cell biology in response to genetic manipulations, pharmacologic agents, and cancer chemotherapy drugs. This unit has experience in in vivo imaging of brain, colon, lung, head and neck cancers as well as multiple other tumor types.  

The Small Animal Imaging Unit supports the following equipment:

  • Bruker 7T Small-Bore MRI
  • PerkinElmer Maestro 2 In Vivo Fluorescence Imaging System
  • PerkinElmer Xenogen IVIS 200 In Vivo Bioluminescence Imaging System
  • Siemens Inveon Micro-PET/CT
  • Small Animal Imaging Suites

X-Ray Crystallography Resource
MUSC has excellent facilities for X-Ray Crystallography to enable researchers at MUSC to engage in high-resolution structural studies of biological macromolecules. The facility, which operates as a University Shared Research Resource, is located in the Department of Biochemistry & Molecular Biology in the Basic Sciences Building. The facility is supported by an X-ray Manager, who is responsible for maintaining the diffraction equipment and assisting users with X-ray data collection and structure determinations, and a Systems Manager for the computing resources.

It includes three components: X-ray diffraction, crystallization and molecular graphics. X-ray diffraction is a purpose-designed diffraction laboratory containing an RU-H3RHB rotating anode generator fitted with Osmic Blue Confocal Optics, a Raxis-IV++ imaging plate system, and an X-Stream cryostat (Rigaku-MSC). In an adjoining room, the crystallization facility contains two large incubators and a stereomicroscope for setting up and monitoring crystallization experiments. Another adjoining room contains four small-scale incubators to test a wide range of temperatures in crystallization.

Adjacent to the diffraction lab, the molecular graphics suite contains a cluster of Unix/Linux workstations for molecular graphics and crystallographic computing. One of these is configured for remote access to the SER-CAT beamline (see below) at the Advanced Photon Source (APS) of Argonne National Lab, allowing synchrotron data to be collected at the home lab. Cluster computing in the form of a 16 node dual-quad core system will be available in Fall 2007. Standard crystallography and modeling software are running on these systems including HKL2000, d*Trek, CCP4, CNS, O, Shake’n’Bake, SHARP, SOLVE, and SYBYL, as well as high-throughput phasing software. Data are stored on a 2.5 TB RAID system, which is backed weekly by tape. An additional 2.5TB of file storage is available on the University’s SAN.


© Medical University of South Carolina | Disclaimer